 The chief executive of Hikma Pharmaceuticals PLC AIM:HIK, OTC:HKMPF, Siggi Olafsson, has stepped down from the role, with a permanent replacement yet to be found. The British injectable medicine business announced today that Olafsson had resigned from the post and from Hikmas board of directors after four years in the role. 